Fluorine F-18
- Generic Name
- Fluorine F-18
- Drug Type
- Small Molecule
- Chemical Formula
- F
- CAS Number
- 13981-56-1
- Unique Ingredient Identifier
- GZ5I74KB8G
- Background
Fluorine-18 is under investigation in clinical trial NCT00870974 (A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions).
A Study to Investigate Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA Gamma 8) Receptor Occupancy of JNJ-64140284 With Newly Developed Transmembrane AMPA Receptor Regulatory Protein (TARP)-Gamma 8 Positron Emission Tomography (PET) [18F]JNJ-64511070 in Healthy Men
Phase 1
Terminated
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2018-10-03
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 22
- Registration Number
- NCT03693391
- Locations
- 🇧🇪
UZ Leuven Gasthuisberg, Leuven, Belgium
FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients
Early Phase 1
Completed
- Conditions
- Breast Cancer
- Interventions
- Procedure: Positron Emission Tomography (PET)Procedure: Positron emission mammography (PEM) When availableProcedure: MR
- First Posted Date
- 2013-05-29
- Last Posted Date
- 2017-08-31
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT01864083
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath